Training to take you through the key stages of system and process auditing, from planning and design to execution and reporting.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information8th April 2026
Summary:
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a £36 million expansion of its AI Airlock programme over the next three years, designed to support the safe and effective use of artificial intelligence in healthcare. The initiative provides a controlled testing environment where developers can work with regulators to refine AI-driven medical technologies before wider deployment. The expanded funding will enable more projects to be supported, strengthen regulatory capabilities, and help position the UK as a global leader in AI-enabled healthcare innovation. Ultimately, the programme aims to improve patient outcomes by ensuring that cutting-edge technologies meet robust safety and performance standards while reaching the market more efficiently.